Cyberonics says FDA warning letter case now closed
This article was originally published in Clinica
Cyberonics, the maker of an implantable vagus nerve stimulation system to treat epilepsy, says the FDA has closed its warning letter case. The company received a warning letter on December 22 after failing to address satisfactorily issues identified in an inspection by the agency's Dallas district office.
You may also be interested in...
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.